PerkinElmer, Inc. (PKI): Price and Financial Metrics
PerkinElmer, Inc. (PKI)
Today's Latest Price: $148.52 USD
Updated Jan 15 7:00pm
Add PKI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 185 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
PKI Stock Summary
- PKI has a higher market value than 87.34% of US stocks; more precisely, its current market capitalization is $16,586,780,463.
- PKI's went public 35.06 years ago, making it older than 92.8% of listed US stocks we're tracking.
- Over the past twelve months, PKI has reported earnings growth of 78.73%, putting it ahead of 85.87% of US stocks in our set.
- Stocks that are quantitatively similar to PKI, based on their financial statements, market capitalization, and price volatility, are GNRC, TFX, XYL, WAB, and FTV.
- PKI's SEC filings can be seen here. And to visit Perkinelmer Inc's official web site, go to www.perkinelmer.com.
PKI Stock Price Chart Interactive Chart >
PKI Price/Volume Stats
| Current price | $148.52 | 52-week high | $162.70 |
| Prev. close | $148.13 | 52-week low | $62.91 |
| Day low | $146.03 | Volume | 824,800 |
| Day high | $149.49 | Avg. volume | 1,138,390 |
| 50-day MA | $140.38 | Dividend yield | 0.19% |
| 200-day MA | $115.47 | Market Cap | 16.63B |
PerkinElmer, Inc. (PKI) Company Bio
PerkinElmer Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The company was founded in 1931 and is based in Waltham, Massachusetts.
PKI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $148.52 | $79.84 | -46% |
We started the process of determining a valid price forecast for Perkinelmer Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Perkinelmer Inc ranked in the 37th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for PKI, they are:
- Interest coverage, a measure of earnings relative to interest payments, is 5.62 -- which is good for besting 56.24% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
- 89% of the company's capital comes from equity, which is greater than 71.18% of stocks in our cash flow based forecasting set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -47% |
| 1% | -47% |
| 2% | -46% |
| 3% | -46% |
| 4% | -45% |
| 5% | -45% |
Want more companies with a valuation profile/forecast similar to that of Perkinelmer Inc? See CRL, MGLN, MMSI, IART, and ITGR.
Loading social stream, please wait...